Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-06

Clinical Trial Update: An Intervention to Examine the Effect of Vitamin D on Urine Protein Levels in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the effect of Vitamin D on urine protein levels in adults with type 2 diabetes and diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Hamad Medical Corporation | Conditions: Diabetic Nephropathies | Phase 3 | Status: UNKNOWN